Previous studies found that NAFLD increased the release of CRP from the liver to blood circulation [58], and it was proposed that serum highly sensitive CRP (hs-CRP) is a good method to reveal possible NAFLD [59]. This evidence concerns the gene CRP and metabolic dysfunction-associated steatotic liver disease.